Steatotic Liver Disease Clinical Trials in Barcelona
5 recruitingBarcelona, Spain
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc.1,350 enrolled342 locationsNCT06318169
Recruiting
Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company4,500 enrolled561 locationsNCT07165028
Recruiting
Phase 1Phase 2
RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
Liver DiseasesCirrhosis, LiverDecompensated Liver Cirrhosis+5 more
Resolution Therapeutics Limited30 enrolled14 locationsNCT06823713
Recruiting
Phase 4
Fibrosis Lessens After Metabolic Surgery
Metabolic dysfunction-associated steatohepatitis (MASH)ObesityNon-Alcoholic Fatty Liver Disease+2 more
Ali Aminian120 enrolled22 locationsNCT06374875
Recruiting
Not Applicable
Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden.
Alcohol Use DisorderAlcohol-related Liver DiseaseMetabolic and Alcohol Related/Associated Liver Disease+1 more
Hospital Universitari Vall d'Hebron Research Institute350 enrolled2 locationsNCT06403332